SABCS: Serum Hormones Can Help ID Benefit of Anastrozole
Women in quartiles 2, 3, and 4 of the estradiol-SHBG ratio demonstrated a relative benefit of anastrozole
SABCS: Outcomes No Worse for Survivors With Less Frequent Mammograms
Breast cancer-specific survival at five years noninferior with less frequent mammograms versus annual mammograms
Geographic Variability Seen in County-Level Preterm Birth Rates
No significant change seen in preterm birth rates between 2007 and 2019 at national level, but increases noted in 15.4 percent of counties
SABCS: 22 Percent of Young BRCA Carriers Conceive After Breast Cancer
No significant difference seen in disease-free survival for those with, without pregnancy; overall survival up for those with pregnancy
In Utero Exposure to Cannabis Tied to Worse Neonatal Outcomes
Impact seen on birth weight, preterm birth, neonatal intensive care unit admission
Changes in Cardiac Structure ID’d in Latinas With Hypertensive Disorders of Pregnancy
Alterations in cardiac structure and systolic and diastolic dysfunction partially mediated by current hypertension
SABCS: Positive Outcomes Seen When Pausing Endocrine Therapy to Become Pregnant
Incidence of breast cancer-free interval events similar for those undergoing ovarian stimulation for cryopreservation or not
CDC: Admission Rate to ICU 1.8 Per 1,000 Live Births for Mothers
Lower rates seen for White non-Hispanic mothers, mothers younger than 25 years; higher rates seen for higher-order births
SABCS: Neoadjuvant Chemo Can Let Breast Cancer Patients Skip Nodal RT
Skipping adjuvant regional nodal irradiation does not increase risk for recurrence or death after neoadjuvant chemo before breast-conserving surgery
Mirvetuximab Soravtansine-Gynx Beneficial for FRα-Positive Ovarian Cancer
Longer progression-free survival seen, and significantly more patients had objective response than those receiving chemo
